Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Pharyngeal Carcinoma”

229 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 229 results

Testing effectiveness (Phase 2)Study completedNCT00091182
What this trial is testing

Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment

Who this might be right for
Childhood Central Nervous System Germ Cell TumorChildhood Extragonadal Germ Cell TumorChildhood Hepatoblastoma+23 more
National Cancer Institute (NCI) 180
Testing effectiveness (Phase 2)Looking for participantsNCT06029270
What this trial is testing

Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Metastatic Nasopharyngeal Cancer

Who this might be right for
Metastatic Nasopharyngeal CarcinomaRecurrent Nasopharyngeal CarcinomaStage IV Nasopharyngeal Carcinoma AJCC v8
National Cancer Institute (NCI) 156
Testing effectiveness (Phase 2)UnknownNCT04921995
What this trial is testing

Immunotherapy and Chemotherapy in Unresectable Recurrent Loco-regionally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Recurrent Nasopharyngeal CarcinomaUnresectable Nasopharyngeal CarcinomaChemotherapy Effect+2 more
Fudan University 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT04862650
What this trial is testing

Cemiplimab, Low-Dose Paclitaxel and Carboplatin for the Treatment of Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Metastatic Head and Neck Squamous Cell CarcinomaMetastatic Hypopharyngeal Squamous Cell Carcinoma+22 more
Marcelo Bonomi
Testing effectiveness (Phase 2)Looking for participantsNCT06323239
What this trial is testing

SBRT and LDRT Combined With PD-1 Antibody and Chemotherapy in r/m Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 148
Testing effectiveness (Phase 2)Study completedNCT02605967
What this trial is testing

Safety and Efficacy Study of PDR001 in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Novartis Pharmaceuticals 122
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07555860
What this trial is testing

Becotatug Vedotin Plus PD-1 Monoclonal Antibody and Radiotherapy for Unresectable Locally Recurrent Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 28
Large-scale testing (Phase 3)Active Not RecruitingNCT05294172
What this trial is testing

KL-A167 Injection Combined With Cisplatin and Gemcitabine vs Placebo Combined With Cisplatin and Gemcitabine in the Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal CarcinomaRecurrent or Metastatic
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. 295
Testing effectiveness (Phase 2)UnknownNCT04405622
What this trial is testing

Toripalimab and Gemcitabine in Recurrent or Metastatic Nasopharyngeal Carcinoma.

Who this might be right for
Nasopharyngeal CarcinomaRecurrent Nasopharyngeal CarcinomaMetastatic Nasopharyngeal Carcinoma+2 more
Sun Yat-sen University 21
Testing effectiveness (Phase 2)UnknownNCT02636231
What this trial is testing

Endostar for Locally Recurrent Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 96
Large-scale testing (Phase 3)UnknownNCT03601975
What this trial is testing

Gemcitabine and Cisplatin With/Without Anlotinib in Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 336
Testing effectiveness (Phase 2)UnknownNCT01086488
What this trial is testing

Foscan®-Mediated Photodynamic Therapy Versus Brachytherapy in Patients With Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Ministry of Health, Malaysia 66
Large-scale testing (Phase 3)Active Not RecruitingNCT06118333
What this trial is testing

A Study Comparing BL-B01D1 With Physician's Choice of Chemotherapy in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma(PANKU-NPC01)

Who this might be right for
Nasopharyngeal Carcinoma
Sichuan Baili Pharmaceutical Co., Ltd. 386
Testing effectiveness (Phase 2)Active Not RecruitingNCT05807880
What this trial is testing

Anlotinib, Penpulimab and Capecitabine in Recurrent/Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Neoplasms
Sun Yat-sen University 59
Testing effectiveness (Phase 2)UnknownNCT05626829
What this trial is testing

Tranilast as a Radiosensitizer in Reradiation of Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal CarcinomaRecurrent Cancer
Jian Guan 18
Testing effectiveness (Phase 2)Looking for participantsNCT05420948
What this trial is testing

Pembrolizumab in Combination With Chemotherapy for Head and Neck Cancer

Who this might be right for
Head and Neck CancerHead and Neck Squamous Cell CarcinomaHead and Neck Neoplasms+2 more
University of Chicago 30
Testing effectiveness (Phase 2)Study completedNCT00747799
What this trial is testing

Study of Combination of Sorafenib With Cisplatin and 5-fluorouracil as First-line Treatment of Recurrence After Radiotherapy Patients Who Failed With Radiotherapy in Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC)

Who this might be right for
Nasopharyngeal Neoplasms
Sun Yat-sen University 54
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06611826
What this trial is testing

GEP Combined With Radiotherapy in Non-locally Treatable Recurrent NPC

Who this might be right for
Nasopharynx Cancer
Zhejiang Cancer Hospital 41
Testing effectiveness (Phase 2)Study completedNCT03906058
What this trial is testing

Anlotinib in Recurrent or Metastatic Nasopharyngeal Carcinoma Patients After Failure of no Less Than Second-line Therapy

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 39
Early research (Phase 1)Study completedNCT01064921
What this trial is testing

Ph I Vorinostat in the Treatment of Advanced Staged Oropharyngeal Squamous Cell Carcinoma

Who this might be right for
Stage III Squamous Cell Carcinoma of the OropharynxStage IV Squamous Cell Carcinoma of the Oropharynx
Ohio State University Comprehensive Cancer Center 27
Next Page
46